Stifel Financial’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.14M | Sell |
11,028
-441
| -4% | -$130K | ﹤0.01% | 1728 |
|
|
2026
Q1 | $3.41M | Buy |
11,469
+502
| +5% | +$162K | ﹤0.01% | 1587 |
|
|
2025
Q4 | $3.33M | Buy |
10,967
+268
| +3% | +$87.7K | ﹤0.01% | 1577 |
|
|
2025
Q3 | $3.65M | Sell |
10,699
-525
| -5% | -$159K | ﹤0.01% | 1480 |
|
|
2025
Q2 | $2.72M | Sell |
11,224
-1,224
| -10% | -$300K | ﹤0.01% | 1627 |
|
|
2025
Q1 | $3.39M | Sell |
12,448
-106
| -0.8% | -$24.8K | ﹤0.01% | 1407 |
|
|
2024
Q4 | $2.32M | Sell |
12,554
-253
| -2% | -$51.7K | ﹤0.01% | 1666 |
|
|
2024
Q3 | $2.88M | Sell |
12,807
-4,366
| -25% | -$786K | ﹤0.01% | 1545 |
|
|
2024
Q2 | $2.45M | Sell |
17,173
-326
| -2% | -$50.2K | ﹤0.01% | 1586 |
|
|
2024
Q1 | $2.74M | Buy |
17,499
+5,042
| +40% | +$812K | ﹤0.01% | 1509 |
|
|
2023
Q4 | $2.25M | Sell |
12,457
-356
| -3% | -$64.4K | ﹤0.01% | 1584 |
|
|
2023
Q3 | $2.3M | Sell |
12,813
-1,344
| -9% | -$266K | ﹤0.01% | 1499 |
|
|
2023
Q2 | $2.52M | Sell |
14,157
-1,434
| -9% | -$330K | ﹤0.01% | 1454 |
|
|
2023
Q1 | $3.36M | Buy |
15,591
+128
| +0.8% | +$30.7K | ﹤0.01% | 1259 |
|
|
2022
Q4 | $3.4M | Sell |
15,463
-262
| -2% | -$48K | 0.01% | 1192 |
|
|
2022
Q3 | $2.12M | Sell |
15,725
-69
| -0.4% | -$11.8K | ﹤0.01% | 1426 |
|
|
2022
Q2 | $2.56M | Buy |
15,794
+506
| +3% | +$79K | ﹤0.01% | 1349 |
|
|
2022
Q1 | $2.88M | Buy |
15,288
+1,213
| +9% | +$258K | ﹤0.01% | 1374 |
|
|
2021
Q4 | $3.81M | Buy |
14,075
+191
| +1% | +$64.5K | 0.01% | 1216 |
|
|
2021
Q3 | $5.04M | Buy |
13,884
+540
| +4% | +$177K | 0.01% | 1012 |
|
|
2021
Q2 | $4.58M | Buy |
13,344
+145
| +1% | +$48K | 0.01% | 1067 |
|
|
2021
Q1 | $4.59M | Buy |
13,199
+2,903
| +28% | +$961K | 0.01% | 1007 |
|
|
2020
Q4 | $2.66M | Sell |
10,296
-863
| -8% | -$238K | ﹤0.01% | 1205 |
|
|
2020
Q3 | $3.2M | Buy |
11,159
+2,095
| +23% | +$492K | 0.01% | 968 |
|
|
2020
Q2 | $1.71M | Sell |
9,064
-703
| -7% | -$114K | ﹤0.01% | 1244 |
|
|
2020
Q1 | $1.19M | Buy |
9,767
+174
| +2% | +$27.2K | ﹤0.01% | 1319 |
|
|
2019
Q4 | $1.59M | Sell |
9,593
-129
| -1% | -$21.4K | ﹤0.01% | 1492 |
|
|
2019
Q3 | $1.18M | Buy |
9,722
+4,567
| +89% | +$607K | ﹤0.01% | 1651 |
|
|
2019
Q2 | $624K | Buy |
5,155
+21
| +0.4% | +$2.67K | ﹤0.01% | 2090 |
|
|
2019
Q1 | $701K | Buy |
5,134
+1,301
| +34% | +$176K | ﹤0.01% | 1862 |
|
|
2018
Q4 | $538K | Buy |
3,833
+282
| +8% | +$37.4K | ﹤0.01% | 1900 |
|
|
2018
Q3 | $613K | Buy |
+3,551
| New | +$597K | ﹤0.01% | 1998 |
|
Other funds holding ONC
BBA
Stifel Financial's ONC Position: Q2 2026 in Review
Stifel Financial reduced its BeOne Medicines Ltd (ONC) stake by 3.8% in Q2 2026, selling an estimated $130K and leaving 11,028 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.
Stifel Financial first reported a position in ONC in Q3 2018 and has held it in 32 quarters since. The position peaked at $5.04M in Q3 2021. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Stifel Financial held 11,028 shares of BeOne Medicines Ltd worth $3.14M as of Q2 2026.
- Stifel Financial sold 441 BeOne Medicines Ltd shares in Q2 2026, an estimated $130K.
- BeOne Medicines Ltd made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #1728 holding.
- Stifel Financial first reported a position in BeOne Medicines Ltd in Q3 2018 and has held it in 32 quarters since.
- Stifel Financial's BeOne Medicines Ltd position peaked at $5.04M in Q3 2021.
- 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.